MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels

MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, R. PYTLÍK, V. PROCHÁZKA, Zuzana PROUZOVÁ, Martin TRBUŠEK, Lenka ZLÁMALÍKOVÁ, Květoslava LIŠKOVÁ, L. KRŮZOVÁ, Marie JAROŠOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, AI. SCHIEFER, O. MERKEL, P. BURDA, Kateřina MACHOVÁ POLÁKOVÁ, Heidi MÓCIKOVÁ, Leoš KŘEN, Jiří MAYER, Marek TRNĚNÝ, CS. ZENT, A. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ. MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels. In 23rd Congress of the European Hematology Association, Stockholm, Sweden. 2018.

Basic information

• Original name: MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels
• Authors: MUSILOVÁ, Kateřina, Ján DEVÁN, Kateřina AMRUZ ČERNÁ, Václav ŠEDA, Gabriela PAVLASOVÁ, R. PYTLÍK, V. PROCHÁZKA, Zuzana PROUZOVÁ, Martin TRBUŠEK, Lenka ZLÁMALÍKOVÁ, Květoslava LIŠKOVÁ, L. KRŮZOVÁ, Marie JAROŠOVÁ, C. KORNAUTH, I. SIMONITSCH-KLUPP, AI. SCHIEFER, O. MERKEL, P. BURDA, Kateřina MACHOVÁ POLÁKOVÁ, Heidi MÓCIKOVÁ, Leoš KŘEN, Jiří MAYER, Marek TRNĚNÝ, CS. ZENT, A. EVANS, Andrea JANÍKOVÁ and Marek MRÁZ.
• Edition: 23rd Congress of the European Hematology Association, Stockholm, Sweden, 2018.

Other information

• Original language: English
• Type of outcome: Conference abstract
• Field of Study: 10606 Microbiology
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology
• Keywords in English: MYC; FOXP1; follicular lymphoma

Abstract

MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels, MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels.

Links

• MUNI/A/0968/2017, interní kód MU: Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V (Acronym: VýDiTeHeMA V)

Investor: Masaryk University, Category A

• MUNI/H/0865/2016, interní kód MU: Name: Coding and Non-coding RNA Networks that Regulate B Cell Receptor Signalling: Implications for Combinatorial Therapy

Investor: Masaryk University, Individual High risk/high gain projects

• NV16-29622A, research and development project: Name: VLIV TERAPEUTICKÉ INHIBICE BCR SIGNALIZACE NA GENOVOU EXPRESI U B BUNĚČNÝCH MALIGNIT A JEJÍ PROGNOSTICKÝ A PREDIKTIVNÍ VÝZNAM
• TE02000058, research and development project: Name: Centrum kompetence pro molekulární diagnostiku a personalizovanou medicínu (Acronym: MOLDIMED)

Investor: Technology Agency of the Czech Republic

• 692298, interní kód MU: Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)

Investor: European Union, Spreading excellence and widening participation